THE Therapeutic Goods Administration (TGA) has asked the Advisory Committee on Medicines Scheduling (ACMS) to consider whether one form of paracetamol - modified release (MR) paracetamol - should become a 'Pharmacist Only' medicine.
The TGA said, following a review and EU decisions to suspend marketing of MR paracetamol products, a move to S3 would maintain access in pharmacies, but give pharmacists the opportunity to counsel patients.
Public comments are invited via this consultation - tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Sep 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Sep 18
